Psilocybin Is Entering State-Regulated Treatment Programs. Has the Science Caught Up?

What psilocybin trials show about depression, safety, and blinding, where Phase 3 data and FDA review stand, and how regulated access differs in Oregon, Colorado, and New Mexico.